301 related articles for article (PubMed ID: 12121906)
1. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Biron KK; Harvey RJ; Chamberlain SC; Good SS; Smith AA; Davis MG; Talarico CL; Miller WH; Ferris R; Dornsife RE; Stanat SC; Drach JC; Townsend LB; Koszalka GW
Antimicrob Agents Chemother; 2002 Aug; 46(8):2365-72. PubMed ID: 12121906
[TBL] [Abstract][Full Text] [Related]
2. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
Evers DL; Komazin G; Shin D; Hwang DD; Townsend LB; Drach JC
Antiviral Res; 2002 Oct; 56(1):61-72. PubMed ID: 12323400
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
Zacny VL; Gershburg E; Davis MG; Biron KK; Pagano JS
J Virol; 1999 Sep; 73(9):7271-7. PubMed ID: 10438815
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.
McSharry JJ; McDonough A; Olson B; Talarico C; Davis M; Biron KK
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1279-81. PubMed ID: 11687477
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
Evers DL; Komazin G; Ptak RG; Shin D; Emmer BT; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2004 Oct; 48(10):3918-27. PubMed ID: 15388453
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Williams SL; Hartline CB; Kushner NL; Harden EA; Bidanset DJ; Drach JC; Townsend LB; Underwood MR; Biron KK; Kern ER
Antimicrob Agents Chemother; 2003 Jul; 47(7):2186-92. PubMed ID: 12821466
[TBL] [Abstract][Full Text] [Related]
7. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.
Komazin G; Ptak RG; Emmer BT; Townsend LB; Drach JC
J Virol; 2003 Nov; 77(21):11499-506. PubMed ID: 14557635
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product.
Underwood MR; Harvey RJ; Stanat SC; Hemphill ML; Miller T; Drach JC; Townsend LB; Biron KK
J Virol; 1998 Jan; 72(1):717-25. PubMed ID: 9420278
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.
Krosky PM; Borysko KZ; Nassiri MR; Devivar RV; Ptak RG; Davis MG; Biron KK; Townsend LB; Drach JC
Antimicrob Agents Chemother; 2002 Feb; 46(2):478-86. PubMed ID: 11796361
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
Chan JH; Chamberlain SD; Biron KK; Davis MG; Harvey RJ; Selleseth DW; Dornsife RE; Dark EH; Frick LW; Townsend LB; Drach JC; Koszalka GW
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):101-23. PubMed ID: 10772705
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.
Underwood MR; Ferris RG; Selleseth DW; Davis MG; Drach JC; Townsend LB; Biron KK; Boyd FL
Antimicrob Agents Chemother; 2004 May; 48(5):1647-51. PubMed ID: 15105116
[TBL] [Abstract][Full Text] [Related]
12. Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.
Selleseth DW; Talarico CL; Miller T; Lutz MW; Biron KK; Harvey RJ
Antimicrob Agents Chemother; 2003 Apr; 47(4):1468-71. PubMed ID: 12654696
[TBL] [Abstract][Full Text] [Related]
13. Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.
Krosky PM; Underwood MR; Turk SR; Feng KW; Jain RK; Ptak RG; Westerman AC; Biron KK; Townsend LB; Drach JC
J Virol; 1998 Jun; 72(6):4721-8. PubMed ID: 9573236
[TBL] [Abstract][Full Text] [Related]
14. Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.
Komazin G; Townsend LB; Drach JC
J Virol; 2004 Jan; 78(2):710-5. PubMed ID: 14694102
[TBL] [Abstract][Full Text] [Related]
15. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus.
O'Brien MS; Markovich KC; Selleseth D; DeVita AV; Sethna P; Gentry BG
Antiviral Res; 2018 Oct; 158():255-263. PubMed ID: 30153445
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.
McGregor A; Choi KY; Cui X; McVoy MA; Schleiss MR
Antiviral Res; 2008 Jun; 78(3):250-9. PubMed ID: 18325607
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.
Gershburg E; Pagano JS
J Virol; 2002 Feb; 76(3):998-1003. PubMed ID: 11773375
[TBL] [Abstract][Full Text] [Related]
19. Comparison of benzimidazole nucleosides and ganciclovir on the in vitro proliferation and colony formation of human bone marrow progenitor cells.
Nassiri MR; Emerson SG; Devivar RV; Townsend LB; Drach JC; Taichman RS
Br J Haematol; 1996 May; 93(2):273-9. PubMed ID: 8639416
[TBL] [Abstract][Full Text] [Related]
20. Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.
McVoy MA; Nixon DE
J Virol; 2005 Sep; 79(17):11115-27. PubMed ID: 16103162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
